“Survival Rate of Gemcitabine Monotherapy After Prior Platinum-Based Chemotherapy for Metastatic Bladder Cancer”. Cermin Dunia Kedokteran, vol. 49, no. 12, Dec. 2022, pp. 693-01, https://doi.org/10.55175/cdk.v49i12.329.